Axcella Health Inc.
AXLADelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted in 2023; its insiders filed their last Form 4 on Mar 3, 2023; 30 institutions reported holding it in 13F filings for Q2 2023, worth $10.5M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 30
- Q2 2023, +1 vs. previous quarter
- 13F value
- $10.5M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding AXLA, Q2 2023
No superinvestor reported holding AXLA at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by Axcella Health Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Koziel MargaretChief Medical Officer | SSale | −679 | $0.58 | −$393.82 | −2.7%24.9K after | |
| Feb 13, 2023 (view filing) | Feb 10 | 3 days | Fehlner PaulSVP & Chief Legal Officer | SSale | +5.22K | $0.66 | +$3.45K | +9.9%58.1K after | |
| Oct 19, 2022 (view filing) | Oct 19 | Same day | Hinshaw WilliamPresident & CEO | SSale | −16.0K | $1.56 | −$25.0K | −16.3%82.0K after | |
| Oct 17, 2022 (view filing)4:42 PM ET | Oct 13 | 4 days | Afeyan Noubar and 4 others10% Owner | PPurchase | +10.4M | $1.64 | +$17.0M | New position3.05M after | 5 lots |
| Oct 17, 2022 (view filing)11:12 AM ET | Oct 13 | 4 days | Nestle SA and 1 other10% Owner | PPurchase | +3.66M | $1.64 | +$6.00M | +49.1%11.1M after | |
| Sep 8, 2022 (view filing) | Sep 6 | 2 days | Koziel MargaretChief Medical Officer | SSale | −547 | $2.52 | −$1.38K | −2.1%25.6K after | |
| Jun 2, 2022 (view filing) | Jun 1 | 1 day | Koziel MargaretChief Medical Officer | SSale | −590 | $2.01 | −$1.19K | −2.2%26.1K after | |
| Mar 18, 2022 (view filing)8:30 AM ET | Mar 16 | 2 days | Afeyan Noubar and 5 others10% Owner | PPurchase | +6.32M | $1.91 | +$12.1M | New position4.47M after | 3 lots |
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Hinshaw WilliamPresident & CEO | PPurchase | +13.1K | $1.91 | +$25.0K | +37.5%48.0K after | |
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Fehlner PaulSVP & Chief Legal Officer | PPurchase | +10.5K | $1.91 | +$20.0K | +101.4%20.8K after |
Top 10 13F holders, Q2 2023
The largest institutional positions in Axcella Health Inc. at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 29,251,545 | $6.39M | 0.28% | 00.0% | Unchanged |
| FMR LLC | 10,272,545 | $2.24M | 0.00% | −760,648−6.9% | Reduced |
| HarbourVest Partners LLC | 6,207,929 | $1.36M | 0.38% | 00.0% | Unchanged |
| Vanguard Group Inc | 823,429 | $179.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 338,313 | $73.9K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 247,915 | $54.1K | 0.00% | −51,515−17.2% | Reduced |
| Bridgeway Capital Management, LLC | 200,409 | $43.7K | 0.00% | 00.0% | Unchanged |
| Edgewood Management LLC | 100,000 | $21.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 77,272 | $16.9K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 72,281 | $15.8K | 0.00% | −47,161−39.5% | Reduced |